Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable...
Conditions: Hepatocellular Carcinoma Interventions: Drug: Atezolizumab; Drug: Bevacizumab; Radiation: Photon radiotherapy Sponsors: Chang Gung Memorial Hospital Not yet recruiting
View ArticleExploratory Study of Irinotecan Liposomes in Maintenance Therapy of...
Conditions: Metastatic Colorectal Cancer Interventions: Drug: Irinotecan Liposome; Drug: Bevacizumab Sponsors: West China Hospital Not yet recruiting
View ArticlePhase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic...
Conditions: Metastatic Colorectal Cancer Interventions: Drug: Irinotecan Liposome; Drug: 5-FU; Drug: LV; Drug: Bevacizumab Sponsors: West China Hospital Not yet recruiting
View ArticleThe Study is Being Conducted to to Explore the Reasonable Dosage and Evaluate...
Conditions: Carcinoma, Hepatocellular Interventions: Drug: HLX53 (1000mg); Drug: HLX53 (2000mg); Drug: HLX10; Drug: HLX04; Other: Placebo Sponsors: Shanghai Henlius Biotech Not yet recruiting
View ArticleA Randomized, Multicenter Phase II Basket Study of Hypofractionated...
Conditions: Gastroesophageal Junction Adenocarcinoma; Liver Cancer Stage IV; Biliary Tract Cancer; Pancreatic Adenocarcinoma; Colorectal Cancer; Gastric Cancer Interventions: Radiation:...
View ArticleAnti-PD-1/PD-L1 Combined With Anti-angiogenic Agents as First-line Treatment...
Conditions: Unresectable Hepatocellular Carcinoma Interventions: Drug: Adebrelimab plus Apatinib; Drug: Adebrelimab plus Bevacizumab; Drug: Camrelizumab plus Apatinib Sponsors: Peking University Cancer...
View ArticleA Study of SC-0191 in Subjects With Metastatic Colorectal Cancer
Conditions: Metastatic Colorectal Cancer Interventions: Drug: SC0191; Drug: SC0191 + Bevacizumab; Drug: SC0191 + 5-FU/LV Sponsors: Tianshu Liu Not yet recruiting
View ArticleSHR-A1811 Combined With Bevacizumab in HER2-positive Breast Cancer With Brain...
Conditions: Breasr Cancer Interventions: Drug: SHR-A1811; Drug: Bevacizumab Sponsors: Huihua Xiong Not yet recruiting
View ArticleSintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Carcinoma Interventions: Drug: Sintilimab, bevacizumab, gemcitabine; Radiation: IMRT Sponsors: Zhejiang Cancer Hospital Not yet recruiting
View Article
More Pages to Explore .....